Field & Main Bank purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 19,053 shares of the company’s stock, valued at approximately $2,448,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MKGAF. Frazier Financial Advisors LLC acquired a new stake in Merck KGaA in the second quarter worth $25,000. Rakuten Securities Inc. acquired a new position in shares of Merck KGaA during the second quarter valued at $27,000. Solstein Capital LLC bought a new position in shares of Merck KGaA during the second quarter worth about $33,000. Delos Wealth Advisors LLC acquired a new stake in shares of Merck KGaA in the 2nd quarter worth about $33,000. Finally, Burk Holdings LLC acquired a new stake in shares of Merck KGaA in the 2nd quarter worth about $39,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Trading Up 3.8%
Merck KGaA stock opened at $164.12 on Friday. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm has a 50-day moving average price of $163.35 and a two-hundred day moving average price of $149.06. The firm has a market capitalization of $21.21 billion, a price-to-earnings ratio of 25.06 and a beta of 0.96. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
